(36 days)
Not Found
No
The document describes standard ultrasound image processing and volume measurement techniques, with no mention of AI or ML.
No
The device is described as a "diagnostic ultrasound system" that "non-invasively determine[s] bladder volume" and "produce[s] on-screen images of anatomy," which indicates it is used for diagnosis rather than treatment.
Yes
The 'Device Description' explicitly states it is a "diagnostic ultrasound system," and its purpose is to "non-invasively determine bladder volume," which is a diagnostic function.
No
The device description explicitly states it is a "hand-held, diagnostic ultrasound system" and mentions projecting "ultrasound energy through the lower abdomen," indicating it includes hardware components for ultrasound generation and reception, not just software.
Based on the provided information, the Signos RT Bladder scanner is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Signos RT Bladder Scanner Function: The Signos RT Bladder scanner uses ultrasound energy to image the bladder within the patient's body and determine its volume. It does not analyze samples taken from the body.
The device is a diagnostic ultrasound system that performs a non-invasive measurement in vivo (within the living body). This falls under the category of medical devices, but specifically not IVDs.
N/A
Intended Use / Indications for Use
Signos RT Bladder scanner projects ultrasound energy through the lower abdomen of a patient to obtain an image of the bladder that is used to non-invasively determine bladder volume. Users must have ultrasound training before using the device.
Product codes
IYO, ITX
Device Description
The Signostics Ltd SignosRT Bladder is a hand-held, diagnostic ultrasound system with an on-screen display. Its purpose is to acquire ultrasound echo data and display it in B-Mode on an LCD display to enable non-invasive volume measurement of a patients bladder.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Bladder / lower abdomen
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Users must have ultrasound training before using the device.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The SignosRT Bladder has been bench tested for imaging performance and measurement accuracy, with tests showing the SignosRT Bladder imaging performance and measurement accuracy to be substantially equivalent to the predicate devices. The measured lateral and axial resolution for the SignosRT Bladder is identical to the predicate SpeqRT Personal Ultrasound System. The measured volume accuracy on a phantom was a maximum of +-9.6%. well within the specified +-15%.
Key Metrics
Measured volume accuracy on a phantom was a maximum of +-9.6%.
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
January 14, 2015
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
Signostics Limited % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street. NW BUFFALO MN 55313
Re: K143493
Trade/Device Name: SignosRT Bladder Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: II Product Code: IYO ITX Dated: December 28, 2014 Received: January 7, 2015
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Robert A. Ochs
Robert Ochs, Ph.D. Acting Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
K143493
Device Name Signos RT Bladder
Indications for Use (Describe)
Signos RT Bladder scanner projects ultrasound energy through the lower abdomen of a patient to obtain an image of the bladder that is used to non-invasively determine bladder volume. Users must have ultrasound training before using the device.
Contraindications
The SignosRT Bladder Scanner is designed for percutaneous scanning only. Do not attempt intracavity imaging; in particular, trans-esophageal, trans-rectal scans are contraindicated.
The SignosRT Bladder Scanner is contraindicated for pregnant patients.
Type of Use (Select one or both, as applicable)
🇿 Prescription Use (Part 21 CFR 801 Subpart D)
□ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwoork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Indications for Use Form
TABLE 1 - SIGNOSRT BLADDER INDICATIONS FOR USE FORM
System: SignosRT Bladder Intended Use: Diagnostic ultrasound imaging of the human body as follows: Clinical Application Mode of Operation PWD General Specific B M CWD Color Combined Other* (Track I Only) (Tracks I & III) Doppler (Specify) (Specify) Ophthalmic Ophthalmic Fetal Abdominal N Intra-operative (Specify) Intra-operative(Neuro) Laparoscopic Pediatric Small Organ (Specify) Neonatal Cephalic Adult Cephalic Fetal Imaging Trans-rectal & Other Trans-vaginal Trans-urethral Trans-esoph. (non-Card.) Musculo-skeletal (Conventional) Musculo-skeletal (Superficial) Intravascular Other (Specify) Cardiac Adult Cardiac Pediatric Intravascular (Cardiac) Cardiac Trans-esoph. (Cardiac) Intra-cardiac Other (Specify) Peripheral Peripheral vessel Vessel Other (Specify)
N= new indication; P=previously cleared by FDA; E=added under AppendixE Additional Comments:
Type of Use (Select one or both, as applicable)
区 Prescription Use (Part 21 CFR 801 Subpart D)
□ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
4
TABLE 2 - SIGNOSRT BLADDER SCANNER INDICATIONS FOR USE FORM
System: SignosRT Bladder
Transducer: S3 (P03479)
Diagnostic ultrasound imaging of the human body as follows : Intended Use:
| Clinical Application | Mode of Operation | |||||||
|---|---|---|---|---|---|---|---|---|
| General | ||||||||
| (Track I Only) | Specific | |||||||
| (Tracks I & III) | B | M | PWD | CWD | Color | |||
| Doppler | Combined | |||||||
| (Specify) | Other* | |||||||
| (Specify) | ||||||||
| Ophthalmic | Ophthalmic | |||||||
| Fetal Imaging | ||||||||
| & Other | Fetal | |||||||
| Abdominal | N | |||||||
| Intra-operative (Specify) | ||||||||
| Intra-operative(Neuro) | ||||||||
| Laparoscopic | ||||||||
| Pediatric | ||||||||
| Small Organ (Specify) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Trans-rectal | ||||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skeletal | ||||||||
| (Conventional) | ||||||||
| Musculo-skeletal | ||||||||
| (Superficial) | ||||||||
| Intravascular | ||||||||
| Other (Specify) | ||||||||
| Cardiac | Cardiac Adult | |||||||
| Cardiac Pediatric | ||||||||
| Intravascular (Cardiac) | ||||||||
| Trans-esoph. (Cardiac) | ||||||||
| Intra-cardiac | ||||||||
| Other (Specify) | ||||||||
| Peripheral | Peripheral vessel | |||||||
| Vessel | Other (Specify) |
N= new indication; P=previously cleared by FDA; E=added under AppendixE Additional Comments:
Type of Use (Select one or both, as applicable)
区 Prescription Use (Part 21 CFR 801 Subpart D)
□ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
5
510(k) Summary
1. Sponsor:
Signostics Ltd PO Box 1048, Pasadena 1284 South Road Clovelly Park, SA 5042 Australia
2. Contact Person: Stewart Bartlett Quality and Regulatory Manager Telephone: +61 (8) 7424 0600
-
- Date Prepared: December 28, 2014
-
- De vice Name : SignosRT Bladder
-
- Proprietary/Marketed Names: SignosRT Bladder
6. Common/Usual Name:
Diagnostic ultrasound system and transducer
7. Classification
Regulatory Class: II
Review Category: Tier II
Ultrasonic Pulsed Echo Imaging System (21 CFR 892.1560, 90-IYO)
(21 CFR 892.1570, 90-ITX)
Diagnostic Ultrasound Transducer
Classification Panel: Radiology
8. Predicate Devices
Portascan Bladder Scanner (K033906)
SignosRT Ultrasound System (K130659)
6
9. Risk Analysis Method Used
Signostics Ltd applied ISO-14971 to the design and development of the SignosRT Bladder. The conclusion from the risk analysis was the device was safe for its intended use and does not pose any unacceptable risks.
10. Basis for Substantial Equivalence - Technological Characteristics
Signostics Ltd believes the SignosRT Bladder described in this Submission is substantially equivalent to the predicate devices as follows:
The SignosRT Bladder is substantially equivalent to the predicate devices listed above. All systems transmit ultrasonic energy into patients, then process received echoes to produce on-screen images of anatomy. All systems allow for B-mode imaging and measurements of volume of a bladder. The indication for use statement of the SignosRT Bladder is identical to the Portascan. The SignosRT Personal Ultrasound system (K130659) is a general ultrasound imaging device with an intended use statement covering a number of areas, including the abdomen which includes the bladder.
All systems enable an estimated bladder volume to be calculated from a single scan or from two scans for more accurate results. The algorithms used to calculate bladder volume are identical for the SignosRT Bladder and the predicate SpeqRT Personal Ultrasound System.
The SignosRT Bladder is identical in construction, materials, and controls to the SignosRT Personal Ultrasound (K130659), with the only difference being the indications for use statement and the software configuration. The patient contact materials are identical. The transducer and operating frequency (3.5MHz) are also identical. Both systems contain sector transducers with annular (circular) acoustic elements generating pie shaped images, have identical operating frequency, identical outer diameter of acoustic crystal, identical acoustic output, and both maintain MI and TI to be